Virtus Fund Advisers’s Allergan plc AGN Stock Holding History

Virtus Fund Advisers’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	$30.5M	Sell	186,555 -238,619	-56%	-$42.8M	0.3%	127
2017 Q3	$87.1M	Buy	425,174 +124,979	+42%	+$29.1M	0.89%	16
2017 Q2	$72.3M	Buy	300,195 +245,017	+444%	+$57.6M	0.71%	28
2017 Q1	$13.2M	Buy	55,178 +54,560	+8,828%	+$12.7M	0.12%	195
2016 Q4	$130K	Hold	618	–	–	﹤0.01%	414
2016 Q3	$142K	Hold	618	–	–	﹤0.01%	410
2016 Q2	$145K	Hold	618	–	–	﹤0.01%	402
2016 Q1	$166K	Hold	618	–	–	﹤0.01%	403
2015 Q4	$193K	Hold	618	–	–	﹤0.01%	379
2015 Q3	$168K	Hold	618	–	–	﹤0.01%	375
2015 Q2	$188K	Hold	618	–	–	﹤0.01%	390
2015 Q1	$184K	Buy	618 +313	+103%	+$89.2K	﹤0.01%	410
2014 Q4	$79K	Hold	305	–	–	﹤0.01%	652
2014 Q3	$74K	Sell	305 -1,442	-83%	-$323K	﹤0.01%	692
2014 Q2	$390K	Buy	+1,747	New	+$362K	﹤0.01%	758

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Baupost Group Boston, Massachusetts $5.42B AUM 22.93% 1-Year Est. Return

Virtus Fund Advisers's AGN Position: Q4 2017 in Review

Virtus Fund Advisers reduced its Allergan plc (AGN) stake by 56% in Q4 2017, selling an estimated $42.8M and leaving 186,555 shares worth $30.5M. The position accounts for 0.3% of the portfolio, ranked #127.

Virtus Fund Advisers first reported a position in AGN in Q2 2014 and has held it in 15 quarters since. The position peaked at $87.1M in Q3 2017. 1,048 funds tracked by Wall St. Rank hold AGN as of Q4 2017.

Virtus Fund Advisers held 186,555 shares of Allergan plc worth $30.5M as of Q4 2017.
Virtus Fund Advisers sold 238,619 Allergan plc shares in Q4 2017, an estimated $42.8M.
Allergan plc made up 0.3% of Virtus Fund Advisers's portfolio in Q4 2017, its #127 holding.
Virtus Fund Advisers first reported a position in Allergan plc in Q2 2014 and has held it in 15 quarters since.
Virtus Fund Advisers's Allergan plc position peaked at $87.1M in Q3 2017.
1,048 funds tracked by Wall St. Rank held Allergan plc as of Q4 2017.

Based on Virtus Fund Advisers's 13F filing for Q4 2017, filed 9 Feb 2018.